Skip to main content

Table 3 Cumulated total cost savings in five years for the French population in 2019-M€ (mean and standard deviation (SD)) together with its 95% bootstrap confidence interval (from 100 simulation runs) from the basic case scenario

From: Economic impact of generic antiretrovirals in France for HIV patients’ care: a simulation between 2019 and 2023

Year

Mean (2019-M€)

SD

95% BCI

1

190.19

1.28

[188.33; 192.35]

2

382.43

1.99

[380.10; 386.02]

3

569.95

2.76

[566.49; 575.29]

4

785.23

3.58

[781.18; 793.12]

5

993.05

5.19

[987.36; 1004.82]

  1. M€ indicates millions of euros, SD Standard Deviation, BCI Bootstrap Confidence Interval